Hympavzi 150 mg, Injektionslösung im Fertigpen

7680695560015 CH-69556 Injektionslösung im Fertigpen

Associated product:

HYMPAVZI sol inj 150 mg/ml stylo pré 1 ml
Hympavzi 150 mg, Injektionslösung im Fertigpen
Hympavzi 150 mg, Injektionslösung im Fertigpen
Hympavzi 150 mg, Injektionslösung im Fertigpen
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
31/03/2025
Summary of Product Characteristics
Français
31/03/2025
Summary of Product Characteristics
Italien
31/03/2025
Patient information leaflet
Allemand
05/02/2025
Patient information leaflet
Français
05/02/2025
Patient information leaflet
Italien
05/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.0062 MG Substance HBESI

Reimbursement information

Public price
CHF 6884.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69556
Drug name
Hympavzi, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
B02BX
Authorization status
Z
Dispensing category
A
First authorization
23/12/2024
Authorization expiration date
22/12/2029
IT Number
06.01.1.
Domain
Human medicine
Field of application
Schwere Hämophilie A ohne Inhibitoren und schwere Hämophilie B ohne Inhibitoren

Package details

Description (FR)
HYMPAVZI sol inj 150 mg/ml stylo pré 1 ml
Description (DE)
HYMPAVZI Inj Lös 150 mg/ml Fertpen 1 ml
Market launch
23/12/2024
Narcotic (BTM)
No